GABRA2

The GABRA2 gene encodes the alpha-2 subunit of the GABA-A receptor, a key component of the brain’s main inhibitory signaling system that helps regulate neuronal excitability and maintain emotional and neurological balance. 

Variants in GABRA2 have been associated with developmental and epileptic encephalopathy, as well as increased susceptibility to alcohol dependence and other neuropsychiatric conditions.

What is GABRA2 (Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha2)?

The GABRA2 gene provides the instructions for making the alpha-2 (α2) subunit of the GABA-A receptor, a key protein in the brain that helps calm down nerve activity. 

GABA-A receptors are activated by gamma-aminobutyric acid (GABA), the brain's primary inhibitory neurotransmitter. When GABA binds to the receptor, it opens a channel that lets chloride ions flow into the neuron, making it less likely to fire. This prevents overstimulation and helps keep brain activity balanced.

GABRA2: A Key Component of GABA-A Receptors

GABRA2 encodes the α2 subunit, one of several building blocks of GABA-A receptors. 

The full receptor is a five-part protein complex, typically made of combinations of α, β, and γ subunits. The α2 subunit is important for inhibitory signaling and for forming connections between nerve cells, especially during brain development.

GABA-A Receptors and Inhibitory Neurotransmission

GABA-A receptors are the primary inhibitory receptors in the brain. They control brain cell activity, prevent seizures, and promote calmness and relaxation. 

Benzodiazepines, barbiturates, and alcohol all target these receptors, enhancing their calming effects.

α2 Subunit Composition and Function

The α2 subunit helps determine the receptor's response to certain drugs and contributes to essential brain functions such as anxiety regulation, reward processing, and pain control. 

It is highly expressed in brain regions like the limbic system, which controls emotion and behavior.

What Do Specific GABRA2 Genetic Variations Mean?

Specific mutations have been associated with:

Developmental and Epileptic Encephalopathy 78 (DEE78)

GABRA2 mutations cause developmental and epileptic encephalopathy 78 (DEE78), a rare but severe childhood epilepsy syndrome characterized by early-onset, treatment-resistant seizures, hypotonia, and severe to profound developmental delay. 

Functional studies show these variants impair GABA A receptor function, leading to reduced inhibitory signaling in the brain. 

Key features include:

• Seizure onset within the first year of life
• Refractory seizures
• Moderate to severe developmental delays
• EEG showing generalized spike-wave discharges
• MRI may be normal or show mild abnormalities

Some patients show partial response to medications like lamotrigine or oxcarbazepine, though many remain drug-resistant.

While most cases are severe, some individuals present with milder phenotypes, including moderate intellectual disability and autism, suggesting variable expressivity based on the specific mutation and other modifiers.

Association with Increased Risk of Substance Use Disorders

Certain non-coding GABRA2 variants, such as rs279871 and rs279858, are strongly associated with a higher risk of alcohol dependence. These variants may affect how the gene is regulated, not how the protein is built.

These genetic differences may also influence treatment response to medications like naltrexone.

Complex Interactions with Other Factors

GABRA2’s effects are not isolated. Its influence on behavior likely involves interactions with other genes and environmental factors, such as stress, trauma, or family history.

When is GABRA2 Genetic Analysis Relevant?

GABRA2 genetic testing may be appropriate in the following settings:

Research Studies on Substance Use Disorders

GABRA2 is best known for its role in research on alcohol use disorder (AUD). Specific GABRA2 variants have been linked to:

• Increased risk of alcohol dependence
• Differences in how people respond to alcohol
• Possible changes in brain activity patterns (e.g., EEG beta waves)

It is also being studied in relation to other substance use disorders, though the evidence is strongest for alcohol.

Research on Neurological and Psychiatric Conditions

Some studies suggest that GABRA2 variants may play a role in:

• Anxiety disorders
• Depression
• Epilepsy, particularly Developmental and Epileptic Encephalopathy 78 (DEE78)

However, GABRA2 is not a routine diagnostic test in clinical practice and is mostly used in research or specialized pharmacogenomic studies.

Test Procedure and Interpretation

GABRA2 testing is performed as a genetic test to look for mutations in the gene that would alter functional protein availability. The following section outlines the testing procedures and interpretation.

Testing Procedure and Preparation

Genetic testing involves blood, saliva, or cheek swab samples, although specialized laboratories may recommend different sample types. 

A cheek swab or saliva sample is easily obtained from the comfort of home, while blood samples typically require a blood draw.

Normal Reference Ranges

Normal reference ranges for GABRA2 genetic testing are considered to be without mutations that can alter the activity of the GABRA2 proteins.

Clinical Implications of Positive GABRA2 Mutations

The clinical implications of a positive GABRA2 mutation test result will vary by individual. However, GABRA2 mutations in symptomatic patients may signal a need for further assessment and possibly treatment, especially in the setting of epileptic symptoms and/or alcohol dependence.

Patients or practitioners with questions about the clinical implications of GABRA2 mutations should seek further assessment with a genetic counselor or expert. 

What Does the Absence of Specific Studied GABRA2 Genetic Variations Mean?

This does not rule out genetic risk even if someone does not carry the specific GABRA2 variants studied in AUD or psychiatric research. Many other genes are involved in substance use, emotional regulation, and brain development.

Also, GABRA2 test results must be interpreted in context—that includes environmental exposure, lifestyle, and clinical history. Alone, they cannot predict disease.

Order Genetic Testing

Click here to compare genetic test panels and order genetic testing for health-related SNPs.